SITAVIG®

Hold Company

LNHC

Learn More

Dosage and Administration

TABLET;BUCCAL

Specification

50MG

Indication

SITAVIG® is used to treat recurrent cold sores in immunocompetent adults.

Use

Instructions for Use

API

ACYCLOVIR

API Structure

We Supply

ACYCLOVIR

Note:

USP/CP/EP
Facility GMP
Product GMP
USMF/CEP/DMF/FDA/KDMF

null

Note:

null

Drug Patent

Patent No	Expiration Date
8592434	2030/6/16
8747896	2027/6/3
8791127	2027/3/23

API Patent

Patent No	Expiration Date
8592434	2030/6/16

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.